Prism Biotech develops benchtop automated cell culture and expansion systems for small-scale clinical applications in regenerative medicine. Spun out from Monash University's Department of Biomedical Engineering, the system reduces manual labour by 60% and improves cell viability consistency. Currently in beta with two private clinics in Melbourne and one in Sydney.